Andy Slee

Andy Slee

Company: Protagenic Therapeutics

Job title: Chief Scientific Officer

Seminars:

Novel BBB-Surpassing Peptide Structure for Unlocking New Treatment Avenues 1:00 pm

• Developing peptide-based drugs for the treatment of affective disorders • Peptides derived from natural genomic sequences with low toxicity and the ability to surpass the blood-brain-barrier • Exploring PTIs lead compound, PT00114, which is currently in clinical trialsRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.